• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

会议报告:为儿童研发更优质药物:第4届欧洲儿科制剂倡议会议

Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference.

作者信息

Walsh Jennifer, Mills Simon

机构信息

Jenny Walsh Consulting Ltd, BioCity, Nottingham, UK.

出版信息

Ther Deliv. 2013 Jan;4(1):21-5. doi: 10.4155/tde.12.135.

DOI:10.4155/tde.12.135
PMID:23323778
Abstract

The fourth annual European Paediatric Formulation Initiative (EuPFI) conference on Formulating Better Medicines for Children was held on 19-20 September 2012 at the Institute of Molecular Genetics Congress Centre, Prague, Czech Republic. The 2-day conference concentrated on the latest advances, challenges and opportunities for developing medicinal products and administration devices for pediatric use, both from European and US perspectives. It was aimed specifically at providing exposure to emerging practical applications, and for illustrating remedies utilized by pediatric drug-development teams to overcome hurdles faced in developing medicines for pediatric patients. The conference format included plenary talks, focus sessions on each of the EuPFI work streams (extemporaneous preparations, excipients, pediatric administration devices, taste masking and taste assessment, age-appropriate formulations), case studies, soapbox sessions and a parallel poster display. This conference report summarizes the keynote lectures and also gives a flavor of other presentations and posters from the conference.

摘要

第四届欧洲儿科制剂倡议组织(EuPFI)关于为儿童研发更优质药物的年度会议于2012年9月19日至20日在捷克共和国布拉格的分子遗传学研究所会议中心举行。为期两天的会议聚焦于从欧洲和美国视角出发,在开发儿科用药品及给药装置方面的最新进展、挑战与机遇。其特别旨在展示新兴的实际应用,并阐述儿科药物研发团队为克服在为儿科患者研发药物过程中所面临的障碍而采用的补救措施。会议形式包括全体大会报告、针对EuPFI各工作流程(临时制剂、辅料、儿科给药装置、掩味和味觉评估、适合不同年龄段的制剂)的焦点会议、案例研究、自由发言环节以及平行海报展示。本会议报告总结了主题演讲内容,同时也展现了会议其他演讲和海报的概貌。

相似文献

1
Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference.会议报告:为儿童研发更优质药物:第4届欧洲儿科制剂倡议会议
Ther Deliv. 2013 Jan;4(1):21-5. doi: 10.4155/tde.12.135.
2
European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children.欧洲儿科制剂倡议组织(EuPFI)——为儿童研发更优质药物的构想
AAPS PharmSciTech. 2017 Feb;18(2):257-262. doi: 10.1208/s12249-016-0584-1. Epub 2016 Jul 15.
3
Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.尤妮斯·肯尼迪·施莱佛国家儿童健康与人类发展研究所儿科制剂倡议:工作组选定报告
Clin Ther. 2008 Nov;30(11):2097-101. doi: 10.1016/j.clinthera.2008.11.017.
4
Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.与味道不佳的儿科药物玩捉迷藏:别忘了赋形剂。
Adv Drug Deliv Rev. 2014 Jun;73:14-33. doi: 10.1016/j.addr.2014.02.012. Epub 2014 Mar 12.
5
Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop.适合儿科应用的适龄固体口服制剂,重点是多颗粒剂和迷你片剂:2019 年 9 月 EuPFI 研讨会摘要。
Eur J Pharm Biopharm. 2020 Aug;153:222-225. doi: 10.1016/j.ejpb.2020.06.012. Epub 2020 Jun 21.
6
European perspectives on pediatric formulations.欧洲对儿科制剂的看法。
Clin Ther. 2008 Nov;30(11):2146-54. doi: 10.1016/j.clinthera.2008.11.016.
7
Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.尤尼斯·肯尼迪·施莱佛国立儿童健康与人类发展研究所儿科制剂倡议:第二届儿科制剂研讨会会议记录。
Clin Ther. 2012 Nov;34(11):S1-10. doi: 10.1016/j.clinthera.2012.09.013.
8
Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.药物制剂:儿科给药的标准和新策略。
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S26-S35. doi: 10.1002/jcph.1138.
9
Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments.儿科制剂给药装置:当前实践、挑战和最新进展概述。
Int J Pharm. 2011 Aug 30;415(1-2):221-31. doi: 10.1016/j.ijpharm.2011.05.048. Epub 2011 May 27.
10
Patent landscape of pediatric-friendly oral dosage forms and administration devices.儿科口服剂型和给药装置的专利全景。
Expert Opin Ther Pat. 2021 Jul;31(7):663-686. doi: 10.1080/13543776.2021.1893691. Epub 2021 Apr 19.

引用本文的文献

1
Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.儿童 2 岁以下人群注射用药时潜在有害辅料暴露的定量研究及其与不良事件的关联分析:一项单中心、回顾性观察研究。
Ther Innov Regul Sci. 2024 Mar;58(2):316-335. doi: 10.1007/s43441-023-00596-0. Epub 2023 Dec 6.
2
Excipients in the Paediatric Population: A Review.儿科人群中的辅料:综述
Pharmaceutics. 2021 Mar 13;13(3):387. doi: 10.3390/pharmaceutics13030387.
3
Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations.
儿科超说明书用药制剂中辅料的安全性及生物制药挑战
Int J Gen Med. 2020 Nov 9;13:1051-1066. doi: 10.2147/IJGM.S280330. eCollection 2020.
4
Adverse drug reactions in hospitalized Colombian children.哥伦比亚住院儿童的药物不良反应
Colomb Med (Cali). 2016 Sep 30;47(3):142-147.
5
Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.用于治疗小儿哮喘的含泼尼松龙纳米颗粒口腔崩解片的研发。
Drug Des Devel Ther. 2015 Nov 20;9:5815-25. doi: 10.2147/DDDT.S86075. eCollection 2015.
6
Solid oral forms availability in children: a cost saving investigation.儿童固体口服剂型的可及性:一项成本节约调查。
Br J Clin Pharmacol. 2014 Nov;78(5):1080-9. doi: 10.1111/bcp.12442.
7
Pharmacovigilance for children's sake.为了儿童的药物警戒。
Drug Saf. 2014 Feb;37(2):91-8. doi: 10.1007/s40264-013-0133-8.